Rafi M Khan

Rafi M. Khan, the notorious Los Angeles stock promoter tied to controversial stock deals dating back a decade, is cooperating with federal investigators in an undisclosed number of fraud probes, the government announced. As part of a plea agreement filed with the U.S. attorney's office this week, Khan pleaded guilty to filing a false tax return for 1991, officials said. He is to return to court for sentencing Oct. 18.

Rafi Khan, a La Canada Flintridge man who was barred from the securities industry for stock manipulation, is emerging as a player in the GenesisIntermedia "short squeeze," adding to what one analyst calls the "soap opera" atmosphere surrounding the company. Khan, who also had a 1999 conviction for tax fraud, has circulated an investment report on Genesis, a Van Nuys company with no earnings that's mostly owned by former Saudi arms dealer Adnan Khashoggi.

ICN Beats Back Khan's Proxy Challenge: The Costa Mesa-based drug company easily won a bitter 10-month proxy battle as dissident investor Rafi M. Khan garnered less than 10% of the votes cast at the firm's annual meeting on his proposal to oust Chairman Milan Panic and eight other board members. ICN said it will pursue legal action against Khan unless he reimburses the company for the $4 million it spent defending itself.

Longtime Los Angeles stock promoter Rafi M. Khan on Wednesday agreed to a five-year ban from the securities industry to settle charges that he manipulated the share prices of Future Communications Inc. in 1993 and L.L. Knickerbocker Co. in 1995. The settlement with the U.S. Securities and Exchange Commission follows Khan's guilty plea with federal prosecutors in July on tax-fraud charges.

Broker Sues New York Times for Libel: Rafi M. Khan, the disgruntled shareholder who is trying to oust the board of ICN Pharmaceuticals Inc., alleged in a suit filed in New York Supreme Court that the newspaper repeatedly published false information about him. An editor named in the suit, which seeks $210 million in damages, declined to comment. Khan, a stockbroker who once touted ICN shares, has been trying since March to unseat ICN Chairman Milan Panic, the former prime minister of Yugoslavia.

Rafi M. Khan, a well-known Southland investment promoter who has been involved with many controversial stocks over the years, was sentenced to three years' probation after pleading guilty last summer to filing a false tax return. The sentence, handed down in U.S. District Court in Los Angeles, includes six months in home detention for the 48-year-old Khan.

A New York federal judge on Wednesday postponed the annual meeting of ICN Pharmaceuticals Inc. until Feb. 1, allowing dissident stockholder Rafi M. Khan more time to revive his twice-foiled drive to oust the Costa Mesa drug company's board of directors. U.S. District Judge John Sprizzo also said that he has referred the Khan case to the U.S.

Longtime Los Angeles stock promoter Rafi M. Khan on Wednesday agreed to a five-year ban from the securities industry to settle charges that he manipulated the share prices of Future Communications Inc. in 1993 and L.L. Knickerbocker Co. in 1995. The settlement with the U.S. Securities and Exchange Commission follows Khan's guilty plea with federal prosecutors in July on tax-fraud charges.

Rafi M. Khan, the dissident investor seeking to oust the chairman of ICN Pharmaceuticals Inc., conceded defeat Monday but vowed to keep pressing for management changes at the company. Shareholders are to vote at the company's annual meeting today on a proposal to replace Chairman Milan Panic and the other eight ICN board members with a new six-member slate that would include Khan, who owns 120,000 shares of the pharmaceutical company's stock.

Rafi M. Khan, a well-known Southland investment promoter who has been involved with many controversial stocks over the years, was sentenced to three years' probation after pleading guilty last summer to filing a false tax return. The sentence, handed down in U.S. District Court in Los Angeles, includes six months in home detention for the 48-year-old Khan.

Rafi M. Khan, the notorious Los Angeles stock promoter tied to controversial stock deals dating back a decade, is cooperating with federal investigators in an undisclosed number of fraud probes, the government announced. As part of a plea agreement filed with the U.S. attorney's office this week, Khan pleaded guilty to filing a false tax return for 1991, officials said. He is to return to court for sentencing Oct. 18.

Controversial Los Angeles stock promoter Rafi M. Khan allegedly manipulated the shares of two companies--Future Communications and L.L. Knickerbocker--in schemes dating to 1993 that included unauthorized trading and parking stock in phony accounts, according to a civil complaint filed Thursday by the Securities and Exchange Commission.

The soaring stock price of collectible doll and toy maker L.L. Knickerbocker nose-dived 20% on Monday in what some investors welcomed as a cooling-off for the overheated shares. The frenzied trading in Knickerbocker stock had driven the price up tenfold in the last six weeks, but the price fell $9.25 a share Monday to close at $37.50 on the Nasdaq market.

ICN Beats Back Khan's Proxy Challenge: The Costa Mesa-based drug company easily won a bitter 10-month proxy battle as dissident investor Rafi M. Khan garnered less than 10% of the votes cast at the firm's annual meeting on his proposal to oust Chairman Milan Panic and eight other board members. ICN said it will pursue legal action against Khan unless he reimburses the company for the $4 million it spent defending itself.

ICN Pharmaceuticals Inc. emerged victorious Tuesday from its bitterly fought proxy battle against Rafi M. Khan and promised to pursue legal action against the dissident shareholder unless it is repaid the $4 million it spent defending itself. "I consider myself a decent human being and I am not revengeful," Chairman Milan Panic said during an hourlong press conference after the company's long-awaited annual meeting, which was held at the drug firm's Costa Mesa headquarters.

Rafi M. Khan, the dissident investor seeking to oust the chairman of ICN Pharmaceuticals Inc., conceded defeat Monday but vowed to keep pressing for management changes at the company. Shareholders are to vote at the company's annual meeting today on a proposal to replace Chairman Milan Panic and the other eight ICN board members with a new six-member slate that would include Khan, who owns 120,000 shares of the pharmaceutical company's stock.